India approves the phase II and III trials of the country's first domestic MRNA-based HGC019 vaccine made by Gennova Biopharmaceuticals after the early-stage study found that the vaccine is safe and effective. (Al Jazeera English) COVID-19 pandemic in India, COVID-19 vaccination in IndiaCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save